Alkermes Director Christopher Wright's Equity Transactions - May 2026

This Form 4 filing reports equity transactions by Christopher I. Wright, a director of Alkermes plc (ALKS), during May 2026. On May 20, 2026, Wright received 11,538 non-qualified stock options with an exercise price of $36.98 and 5,409 restricted stock units (RSUs). The following day, May 21, 2026, Wright exercised 6,142 RSUs that had fully vested, converting them to ordinary shares. Additionally, on May 21, Wright sold 1,475 ordinary shares at $36.95 per share. Following these transactions, Wright's direct holdings include 27,680 ordinary shares, 11,538 stock options, and 5,409 RSUs. The transactions represent routine equity compensation and portfolio management activities by a company director.